Biology

Transthyretin

Health

Medicine

Phase I First-in-Human Trial of ALN-TTRsc, A Novel RNA Interference Therapeutic for the Treatment of Familial Amyloidotic Cardiomyopathy (FAC) Tracy Zimmermann,1 Verena Karsten,1 Jamie Harrop,1 Amy Chan,1 Joseph Chiesa,2

Document is deleted from original location.
Use the Download Button below to download from the Web Archive.

File Size: 784,91 KB